Global Intrathecal Pumps Market- Market Overview:

The global intrathecal pumps market is expected to grow from USD 231.5 million in 2022 to USD 355.2 million by 2030, at a CAGR of 5.5% during the Projection period 2023-2030. The growth of the radiopharmaceutical market is mainly driven by the increased usage in the healthcare sector.

Intrathecal delivery is becoming more significant in the therapy of chronic pain. Intrathecal pumps provide precisely regulated and prolonged drug delivery in the body to treat a variety of chronic illnesses, including multiple sclerosis and cancer pain. In order to give the medication to the spinal cord directly, the intrathecal pump and catheters are surgically inserted under the skin, providing effective pain relief. Additionally, these pumps are accurate, portable, easy to operate, and power-efficient. According to estimates from the World Health Organization (WHO), one in ten persons experiences chronic pain for the first time each year. As a result, the market for intrathecal pumps has enormous potential. The primary driver predicted to fuel the industry's growth is the increased incidence of chronic diseases like cancer, back pain, and chronic pancreatitis. For instance, the National Cancer Institute estimates that there were around 16.9 million cancer patients in the United States as of January 2019. Therefore, it is anticipated that rising cancer rates will generate significant growth prospects. Intrathecal pump technology advances are anticipated to accelerate industry expansion. Its adoption rate is expected to rise as a result of developments including better pump delivery modes, catheter design, and safety features. Baclofen poses a problem to the industry because it has risks that could be fatal, including seizure, rhabdomyolysis, coma, and death. It is predicted that a rising number of product releases by well-known enterprises would accelerate industry growth. Amneal Pharmaceuticals stated in June 2022 that it would introduce LYVISPAH (baclofen) to treat the spasticity brought on by multiple sclerosis and other spinal cord illnesses.

Sample Request: - Global Intrathecal Pumps Market

Market Dynamics:

Drivers:                          

• Rise in Demand

In the elderly population, pain is a common and clinically significant condition. However, the use of intrathecal pumps has produced superior outcomes when treating elderly people who are suffering from pain. Unfortunately, it can be difficult to assess pain in senior patients, largely because of the complexity of their many co-morbid conditions. As the population of the elderly increases, so will the demand for intrathecal pumps. According to WHO estimates, there will be 2 billion people worldwide who are 60 years of age or older by 2050. Market growth is predicted to be fueled by a pump's ability to deliver medicines where they are most frequently needed, as well as by their improved potency, decreased systemic exposure, and the dosage required to produce the desired pharmacologic effect.

Restraints:                                             

• Stringent Regulations

The American Food and Drug Administration has not yet given its approval for the use of all intrathecal pumps. The FDA has alerted individuals and medical professionals about the negative effects of utilising drugs that have not been FDA-approved. Furthermore, more stringent safety requirements must be met by medications that have been approved for intrathecal use. Risks including dosing errors, infections, pump failure, opioid withdrawal, and other diseases like muscular spasms, cognitive issues, pain, fever, vomiting, weakness, and heart or respiratory distress could hinder the market's progress. Examples of surgical problems include catheter site irritation, CSF leak, and surgical site infection. Surgical infections occur after intrathecal implants in 0.5% to 2.0% of cases.

Opportunities:

• Rise in Usage

Intrathecal pumps are seen to be a useful tool for pain relief, however there may be certain hazards and issues with these pumps that need to be addressed. Due to flaws in the surgically implanted pumps, which are blamed for more than a dozen deaths, the U.S. Food and Drug Administration filed a court order against Medtronic directing the company to stop producing and selling its SynchroMed II intrathecal pain pumps in 2015. Devices either lost power or unintentionally administered high or low medicine doses to patients. Thus, one of the factors to guard against medical issues is product quality and safety.

Challenges:

• Rise in Cancer Patients

Cancer patients frequently utilise intrathecal pumps to relieve their persistent pain. A survey by the International Agency for Research on Cancer (IARC) in 2012 estimated that there were 14.1 million new cases of cancer and an 8.2 million-person mortality rate. In a 2011 survey, the World Health Organization (WHO) and International Pain Community estimated that the prevalence of chronic pain in cancer patients ranged from more than 75% for those with advanced disease to roughly 25% for those who had just been diagnosed. The prevalence of chronic illnesses will cause a significant increase in the need for sophisticated intrathecal pumps in the coming years.

Segmentation Analysis:

The global intrathecal pumps market has been segmented based on type, application and region.

By Type

The type segment is morphine, baclofen, ziconotide, clonidine, bupivacaine, and others. The morphine procedures segment led the largest share of the intrathecal pumps market with a market share of around 39.5% in 2022. In terms of intrathecal drug delivery, morphine is regarded as the gold standard due to its high receptor affinity, stability, and vast user experience. Additionally, the U.S. FDA has authorised the use of morphine for the treatment of chronic intrathecal pain. Additionally, compared to systemic opioids, long-term intrathecal morphine has less side effects, which is anticipated to promote the expansion of this market.

By Application

The application segment is pain and spasticity. The spasticity segment led the largest share of the intrathecal pumps market with a market share of around 56% in 2022. A number of industry participants are concentrating on creating treatments to treat spasticity. For instance, Lioresal Intrathecal (baclofen) is injected into the fluid surrounding a person's spinal cord as part of Medtronic's Intrathecal Baclofen Therapy (ITB) to treat severe spasticity. Additionally, one of the main drivers of the segment growth is the rise in stroke incidence globally. For instance, according to a report released in 2019 by the American College of Cardiology Foundation, approximately 795,000 Americans get new or recurrent strokes each year, or one every 40 seconds on average.

Global Intrathecal Pumps Market- Sales Analysis.

The sale of the intrathecal pumps market expanded at a CAGR of 4.5% from 2016 to 2022.

Implantable infusion devices called intrathecal pumps are surgically positioned beneath the patient's skin in the belly. These can deliver medication to the spine using a catheter, a short, flexible tube. These intrathecal drug pain pump implants are typically chosen when a patient needs long-term medication and other options are expensive or ineffective because they can provide exact doses of medication from one or any combination of reservoirs without sophisticated pumping. By adjusting the intrathecal pumps' medication delivery in accordance with doctor's instructions, a medicine can be infused over a prolonged period of time and supplied at constant or variable rates. An external needle injection is used to replace the medication reservoir through a self-sealing septum in the implanted infusion pump.

One of the main drivers of the global market is the rise in the number of people affected by cancer and chronic pain. When treating these disorders, intrathecal pumps are frequently utilised to give medications via the intrathecal route. Around 17.0 million new instances of cancer and 9.5 million cancer-related deaths were reported globally in 2018, according to estimates from the International Agency for Research on Cancer (IARC). By 2040, the rise in the number of elderly people is predicted to cause 27.5 million new cases of cancer and 16.3 million cancer deaths worldwide. The number of people who experience disease-causing pain is rising, and a number of important contributors are changing lifestyles, increased urbanisation, and demographic shifts.

Thus, owing to the aforementioned factors, the global intrathecal pumps market is expected to grow at a CAGR of 5.5% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the intrathecal pumps market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the intrathecal pumps market and held a 38% share of the market revenue in 2022.

• The North America region witnessed a major share. The rising prevalence rates of cancer, persistent postoperative pain, and neck discomfort, which make it easier to take painkillers, are anticipated to propel market expansion. For instance, according to the Centers for Disease Control and Prevention (CDC) 2020, 50 million Americans suffer from chronic pain (US). Along with establishing various programmes to raise healthcare quality and costs in the US, patient safety is a priority. Another element fueling market expansion is the fact that North America spends more than other areas on healthcare requirements. The North American Spine Society (NASS) has created coverage guidelines for spinal intrathecal delivery systems for the management of chronic pain as of January 2021.
• Asia-Pacific is anticipated to experience significant growth during the Projection period. The Asia Pacific region has a sizable patient base, which is anticipated to increase product demand. It is anticipated that the growth of pain treatment facilities in China, Singapore, Japan, and India will accelerate the use of intrathecal pumps. In Southeast Asia, Singapore Pain Care Center (SPCC) is one example of a pain management facility that offers an alternative to open surgery. The high frequency of pain-related illnesses, rising R&D spending, and an increase in the number of pain care facilities in the U.S. & Canada all played a significant role in the expansion of the region. The demand for efficient and sophisticated intrathecal pumps is growing since the incidence of cancer in the United States is increasing quickly.

Global Intrathecal Pumps Market - Country Analysis:

• Germany

Germany's intrathecal pumps market size was valued at USD 17.9 million in 2022 and is expected to reach USD 27.67 million by 2030, at a CAGR of 5.6% from 2023 to 2030. This is attributed to a strengthening economy and insurance regulations. Economic expansion in the region's developing nations is anticipated to raise the patient population's disposable income, which is projected to boost healthcare costs.

• China

China’s intrathecal pumps market size was valued at USD 18.04 million in 2022 and is expected to reach USD 28.32 million by 2030, at a CAGR of 5.8% from 2023 to 2030. In some Asian nations, like China, economic development has raised investments in healthcare infrastructure, which is likely to spur the use of hospital equipment. Governments in these countries are concentrating on expanding healthcare coverage in order to enable access to improved healthcare facilities, working with private insurance companies.

• India

India's intrathecal pumps market size was valued at USD 13.8 million in 2022 and is expected to reach USD 21.5 million by 2030, at a CAGR of 5.7% from 2023 to 2030. The rising prevalence rates of cancer, persistent postoperative pain, and neck discomfort, which make it easier to take painkillers, are anticipated to propel market expansion.

Key Industry Players Analysis:

To increase their market position in the global intrathecal pumps market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.   

• Medtronic plc
• Codman & Shurtleff
• Medallion Therapeutics
• Tricumed GmbH
• Arrow International Inc.

Latest Development:

• In January 2021, A US$33 Mn award was made to Flowonix Medical. This medical device company is situated in the US and focuses on implanted medicine delivery systems. SWK Holdings (SWKH), a specialised finance company that works with small- and mid-sized commercial-stage life-science firms, provided a US$ 10 Mn debt facility as part of the agreement.
• In October 2020, Baxter International Inc. urgently corrected all of their spectrum infusion pumps to strengthen safety recommendations on proper cleaning techniques for the pumps. The pumps' efficiency and effectiveness were decreased because the cleaning instructions weren't followed.
• In February 2020, A 40 ml pump for intrathecal medication administration was unveiled by Flowonix Medical.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	5.5%
Market Size	231.5 million in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Type, By Application, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Medtronic plc, Codman & Shurtleff, Medallion Therapeutics, Tricumed GmbH, and Arrow International Inc.
By Type	Morphine Baclofen Ziconotide Clonidine Bupivacaine Others
By Application	Pain Spasticity
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Intrathecal Pumps Market By Type:

• Morphine
• Baclofen
• Ziconotide
• Clonidine
• Bupivacaine
• Others

Global Intrathecal Pumps Market By Application:

• Pain
• Spasticity

Global Intrathecal Pumps Market By Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- A transparent governance framework is necessary to foster a collaborative working atmosphere. Corruption and a lack of transparency have caused several difficulties in the intrathecal pumps market. The main causes of this lack of openness are the current political uncertainty and unpredictability. Corruption reduces stakeholders' trust in commercial companies and governmental entities by encouraging fraudulent operations, making corporate processes such as licencing and contracting more difficult, and lowering law enforcement. Rising bureaucratic corruption frequently hinders economic progress, making it difficult for markets such as intrathecal pumps market to thrive.

Economic Factors- In established markets nearing saturation, meeting intrathecal pumps market  growth objectives may be more difficult. As a result, while selecting countries for international expansion, the industry lifecycle stage must be considered. When considering whether to expand abroad, intrathecal pumps market should consider the rates of economic growth in various countries. In countries with strong economic growth, there are more opportunities to pursue long-term growth goals. When the economy grows slowly, consumer spending becomes more limited, which has a direct impact on the revenue growth of the intrathecal pumps market .

Social Factors- Respect for hierarchy and social class stratification are two key social factors that may influence marketing, advertising, and human resource management plans for the intrathecal pumps market sector. intrathecal pumps market is most at ease when confronting nations with substantial power distances in hierarchical institutions and formal work cultures. The development in socioeconomic stratification is another indicator of the need for effective market segmentation tactics. This is due to the inability of intrathecal pumps market to effectively target many groups from various social classes using the same marketing mix.

Technological Factors- Nations with superior technological infrastructure should gain from the intrathecal pumps market  because these countries make it easier for enterprises to achieve goals such as cost reduction, innovation, and value creation. Because a well-developed technological infrastructure makes it easier for competitors to mimic, it will be more difficult for intrathecal pumps market to harness technology to gain a durable competitive advantage. The velocity and advancement of technical innovation may have an impact on the market and industry as a whole. By evaluating upcoming technological innovation trends, the intrathecal pumps market  will be able to comprehend the rate of new product creation, the length of the product life cycle, and the specific features that consumers need.

Environmental Factors- The application of the closed-loop, circular economy concept is becoming more popular in a variety of countries and industries. Material reuse and recycling can be facilitated by businesses that have conducive institutional frameworks. Similarly, recycling is a popular activity all across the world. The intrathecal pumps market may benefit from these sustainability trends and use them as a tool to achieve financial goals by cutting production costs and environmental expenses.

Legal Factors- Companies such as intrathecal pumps market benefit from strict adherence to intellectual property legislation since it protects their patents against infringement and provides them with a long-term competitive advantage. Several federal and state laws are in existence in several countries to protect consumers from potential economic exploitation. In the age of digital technology, consumer privacy laws have become more stringent. To avoid lawsuits, the intrathecal pumps market sector must closely adhere to data privacy rules when conducting online transactions.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Type
     • 3.2. Market Attractiveness Analysis By Application
     • 3.3. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Rise in Demand
   • 3. Restraints
     • 3.1. Stringent Regulations
   • 4. Opportunities
     • 4.1. Rise in Usage
   • 5. Challenges
     • 5.1. Rise in Cancer Patients

6. Global Intrathecal Pumps Market Analysis and Projection, By Type
   • 1. Segment Overview
   • 2. Morphine
   • 3. Baclofen
   • 4. Ziconotide
   • 5. Clonidine
   • 6. Bupivacaine
   • 7. Others
7. Global Intrathecal Pumps Market Analysis and Projection, By Application
   • 1. Segment Overview
   • 2. Pain
   • 3. Spasticity
8. Global Intrathecal Pumps Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

9. Global Intrathecal Pumps Market-Competitive Landscape
   • 1. Overview
   • 2. Market Share of Key Players in the Intrathecal Pumps Market
     • 2.1. Global Company Market Share
     • 2.2. North America Company Market Share
     • 2.3. Europe Company Market Share
     • 2.4. APAC Company Market Share
   • 3. Competitive Situations and Trends
     • 3.1. Technology Launches and Developments
     • 3.2. Partnerships, Collaborations, and Agreements
     • 3.3. Mergers & Acquisitions
     • 3.4. Expansions

10. Company Profiles
    • Medtronic plc
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Technology Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Codman & Shurtleff
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Technology Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Medallion Therapeutics
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Technology Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Tricumed GmbH
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Technology Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Arrow International Inc.
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Technology Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis

List of Table

1. Global Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
2. Global Morphine, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
3. Global Baclofen, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
4. Global Ziconotide, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
5. Global Clonidine, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
6. Global Bupivacaine, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
7. Global Others, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
8. Global Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
9. Global Pain, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
10. Global Spasticity, Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
11. Global Intrathecal Pumps Market, By Region, 2023–2030 (USD Million)
12. North America Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
13. North America Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
14. USA Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
15. USA Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
16. Canada Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
17. Canada Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
18. Mexico Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
19. Mexico Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
20. Europe Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
21. Europe Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
22. Germany Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
23. Germany Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
24. France Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
25. France Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
26. UK Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
27. UK Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
28. Italy Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
29. Italy Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
30. Spain Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
31. Spain Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
32. Asia Pacific Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
33. Asia Pacific Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
34. Japan Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
35. Japan Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
36. China Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
37. China Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
38. India Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
39. India Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
40. South America Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
41. South America Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
42. Brazil Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
43. Brazil Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
44. Middle East and Africa Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
45. Middle East and Africa Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
46. UAE Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
47. UAE Intrathecal Pumps Market, By Application 2023–2030 (USD Million)
48. South Africa Intrathecal Pumps Market, By Type, 2023–2030 (USD Million)
49. South Africa Intrathecal Pumps Market, By Application 2023–2030 (USD Million)

List of Figures 

1. Global Intrathecal Pumps Market Segmentation
2. Intrathecal Pumps Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Intrathecal Pumps Market Attractiveness Analysis By Type
9. Global Intrathecal Pumps Market Attractiveness Analysis By Application
10. Global Intrathecal Pumps Market Attractiveness Analysis By Region
11. Global Intrathecal Pumps Market: Dynamics
12. Global Intrathecal Pumps Market Share By Type (2023 & 2030)
13. Global Intrathecal Pumps Market Share By Application (2023 & 2030)
14. Global Intrathecal Pumps Market Share by Regions (2023 & 2030)
15. Global Intrathecal Pumps Market Share by Company (2021)